Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-86,002
Closed -$2.55M 67
2024
Q3
$2.55M Buy
86,002
+34,808
+68% +$1.08M 0.74% 30
2024
Q2
$1.73M Buy
51,194
+297
+0.6% +$10.3K 1.07% 26
2024
Q1
$1.84M Buy
50,897
+143
+0.3% +$4.95K 1.11% 26
2023
Q4
$1.66M Sell
50,754
-879
-2% -$27.2K 1.04% 28
2023
Q3
$1.68M Sell
51,633
-821
-2% -$26.3K 1.15% 27
2023
Q2
$1.53M Sell
52,454
-6,040
-10% -$166K 1.03% 28
2023
Q1
$1.64M Sell
58,494
-1,013
-2% -$28.5K 1.19% 26
2022
Q4
$1.62M Buy
59,507
+1,526
+3% +$40.7K 1.23% 23
2022
Q3
$1.38M Buy
57,981
+214
+0.4% +$5.87K 1.16% 22
2022
Q2
$1.62M Buy
57,767
+17,471
+43% +$508K 1.29% 21
2022
Q1
$1.18M Buy
40,296
+1,482
+4% +$46.1K 0.82% 37
2021
Q4
$1.35M Buy
+38,814
New +$1.38M 0.9% 35

Other funds holding GNTX

Berkeley Inc's GNTX Position: Q4 2024 in Review

Berkeley Inc sold out of Gentex (GNTX) in Q4 2024, closing a stake of 86,002 shares — an estimated $2.55M sold.

Berkeley Inc first reported a position in GNTX in Q4 2021 and held it in 12 quarters. The position peaked at $2.55M in Q3 2024. 534 funds tracked by Wall St. Rank hold GNTX as of Q4 2024.

  • Berkeley Inc reported no remaining Gentex position as of Q4 2024 after selling out during the quarter.
  • Berkeley Inc sold 86,002 Gentex shares in Q4 2024, an estimated $2.55M.
  • Berkeley Inc first reported a position in Gentex in Q4 2021 and held it in 12 quarters.
  • Berkeley Inc's Gentex position peaked at $2.55M in Q3 2024.
  • 534 funds tracked by Wall St. Rank held Gentex as of Q4 2024.

Based on Berkeley Inc's 13F filing for Q4 2024, filed 5 Mar 2025.